quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:25:55·36d
SECFiling
Ovid Therapeutics Inc. logo

SEC Form 10-K filed by Ovid Therapeutics Inc.

OVID· Ovid Therapeutics Inc.
Health Care
Original source

Companies

  • OVID
    Ovid Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Dec 11UpdateRoth Capital$3.00
  • Nov 17UpdateLeerink Partners-
  • Oct 9UpdateOppenheimer$7.00
  • Aug 8UpdateB. Riley Securities$3.00
  • Jun 18UpdateOppenheimer-
  • Apr 30UpdateB. Riley Securities$9.00

Related

  • SEC2d
    SEC Form S-3 filed by Ovid Therapeutics Inc.
  • SEC4d
    Ovid Therapeutics Inc. filed SEC Form 8-K: Other Events
  • INSIDER14d
    SEC Form 4 filed by Papadopoulos Stelios
  • INSIDER14d
    SEC Form 4 filed by Fitzgerald Kevin Joseph
  • INSIDER14d
    SEC Form 4 filed by Friedman Bart
  • PR16d
    Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
  • INSIDER29d
    SEC Form 4 filed by Levin Jeremy M
  • SEC36d
    SEC Form S-8 filed by Ovid Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022